NPX800
CAS No. 1693734-80-3
NPX800( CCT361814 )
Catalog No. M28911 CAS No. 1693734-80-3
NPX800 is an inhibitor of heat shock factor 1 (HSF1) and can be used in studies about the treatment of cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 300 | In Stock |
|
| 5MG | 239 | In Stock |
|
| 10MG | 375 | In Stock |
|
| 25MG | 626 | In Stock |
|
| 50MG | 873 | In Stock |
|
| 100MG | 1190 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNPX800
-
NoteResearch use only, not for human use.
-
Brief DescriptionNPX800 is an inhibitor of heat shock factor 1 (HSF1) and can be used in studies about the treatment of cancer.
-
DescriptionNPX800 is an inhibitor of heat shock factor 1 (HSF1) and can be used in studies about the treatment of cancer.(In Vitro):NPX800 inhibits cell viability of U20S with IC50 of 56 nM.
-
In VitroNXP800 (example 169) inhibits U20S cells viability (IC50=0.056 μM).
-
In Vivo——
-
SynonymsCCT361814
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorEg5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1693734-80-3
-
Formula Weight569.63
-
Molecular FormulaC32H32FN5O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (175.55 mM)
-
SMILESO=C(NC1=CC=C(F)C(=C1)NC(=O)C=2C=CC=3N=C(C=CC3C2)CN4CCN(CC)CC4)C5=CC=C6OCCOC6=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sunder-Plassmann N, et al. Synthesis and biological evaluation of new tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin Eg5. Bioorg Med Chem. 2005 Nov 15;13(22):6094-111.
molnova catalog
related products
-
PU-H71 HCl
PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT.
-
TRC051384
TRC051384 is an inducer of heat shock protein Hsp70, activating heat shock factor-1 and enhancing Hsp72 expression in neurons and glial cells.
-
KNK-437
An inhibitor of Heat shock protein (HSP) synthesis that dose-dependently inhibits the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in human colon carcinoma cells.
Cart
sales@molnova.com